365 related articles for article (PubMed ID: 18005393)
1. Chromogranins A and B and secretogranin II: evolutionary and functional aspects.
Montero-Hadjadje M; Vaingankar S; Elias S; Tostivint H; Mahata SK; Anouar Y
Acta Physiol (Oxf); 2008 Feb; 192(2):309-24. PubMed ID: 18005393
[TBL] [Abstract][Full Text] [Related]
2. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system.
Helle KB
Results Probl Cell Differ; 2010; 50():21-44. PubMed ID: 20217490
[TBL] [Abstract][Full Text] [Related]
3. New insights into granin-derived peptides: evolution and endocrine roles.
Zhao E; Zhang D; Basak A; Trudeau VL
Gen Comp Endocrinol; 2009; 164(2-3):161-74. PubMed ID: 19523383
[TBL] [Abstract][Full Text] [Related]
4. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects.
Helle KB
Biol Rev Camb Philos Soc; 2004 Nov; 79(4):769-94. PubMed ID: 15682870
[TBL] [Abstract][Full Text] [Related]
5. Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
Nunzi MG; Mugnaini E
Neuroscience; 2009 Sep; 162(3):673-87. PubMed ID: 19217926
[TBL] [Abstract][Full Text] [Related]
6. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.
Feldman SA; Eiden LE
Endocr Pathol; 2003; 14(1):3-23. PubMed ID: 12746559
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A.
Hendy GN; Bevan S; Mattei MG; Mouland AJ
Clin Invest Med; 1995 Feb; 18(1):47-65. PubMed ID: 7768066
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
[TBL] [Abstract][Full Text] [Related]
9. Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells.
Hosaka M; Watanabe T; Sakai Y; Uchiyama Y; Takeuchi T
Mol Biol Cell; 2002 Oct; 13(10):3388-99. PubMed ID: 12388744
[TBL] [Abstract][Full Text] [Related]
10. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
Portela-Gomes GM; Grimelius L; Stridsberg M
Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of sorting of secretory proteins and formation of secretory granules in neuroendocrine cells].
Chanat E
C R Seances Soc Biol Fil; 1993; 187(6):697-725. PubMed ID: 7834494
[TBL] [Abstract][Full Text] [Related]
12. Granin-derived peptides.
Troger J; Theurl M; Kirchmair R; Pasqua T; Tota B; Angelone T; Cerra MC; Nowosielski Y; Mätzler R; Troger J; Gayen JR; Trudeau V; Corti A; Helle KB
Prog Neurobiol; 2017 Jul; 154():37-61. PubMed ID: 28442394
[TBL] [Abstract][Full Text] [Related]
13. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
14. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.
Strid H; Simrén M; Lasson A; Isaksson S; Stridsberg M; Öhman L
J Crohns Colitis; 2013 Dec; 7(12):e615-22. PubMed ID: 23694857
[TBL] [Abstract][Full Text] [Related]
15. Purification, pH-dependent conformational change, aggregation, and secretory granule membrane binding property of secretogranin II (chromogranin C).
Park HY; So SH; Lee WB; You SH; Yoo SH
Biochemistry; 2002 Jan; 41(4):1259-66. PubMed ID: 11802725
[TBL] [Abstract][Full Text] [Related]
16. Presence of secretogranin II and high-capacity, low-affinity Ca2+ storage role in nucleoplasmic Ca2+ store vesicles.
Yoo SH; Chu SY; Kim KD; Huh YH
Biochemistry; 2007 Dec; 46(50):14663-71. PubMed ID: 18020452
[TBL] [Abstract][Full Text] [Related]
17. Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions.
Helle KB
Regul Pept; 2010 Nov; 165(1):45-51. PubMed ID: 19800929
[TBL] [Abstract][Full Text] [Related]
18. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors.
Conlon JM
Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574
[TBL] [Abstract][Full Text] [Related]
19. Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC.
Hotta K; Hosaka M; Tanabe A; Takeuchi T
J Endocrinol; 2009 Jul; 202(1):111-21. PubMed ID: 19357184
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and processing of chromogranin A and secretogranin II in relation to the secretory status of endocrine cells.
Peinado JR; Vazquez-Martinez R; Cruz-García D; Ruiz-Navarro A; Anouar Y; Tonon MC; Vaudry H; Gracia-Navarro F; Castano JP; Malagón MM
Endocrinology; 2006 Mar; 147(3):1408-18. PubMed ID: 16357044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
